Eugenol sübstitüe yeni karbamat türevlerinin sentezi ve kolinesteraz enzimlerinin inhibisyonu
Bu çalışmada, karbamat grubu içeren 14 yeni eugenol türevleri sentezlenmiş ve bunların asetilkolinesteraz (AChE) ve bütirilkolinesteraz (BuChE) enzimleri üzerine inhibitör etkileri incelenmiştir. 4-allil-2-metoksifenil-(3,4- diklorofenil)karbamat (3f) 71.6 µM’lık IC50 değeri ile en iyi AChE inhibitörü olarak belirlenmiştir. 4-allil-2- metoksifenil(3-metoksifenil)karbamat (3a) 0.58 µM’lık IC50 değeri ile BuChE’ye karşı en güçlü inhibisyonu sergilemiştir. Ayrıca sentezlenen bileşikler için yapı-aktivite ilişkileri de incelenmiştir.
Synthesis and cholinesterase enzymes inhibition of novel eugenol substituted carbamate derivatives
In this study, 14 novel eugenol derivatives with the carbamate moiety were synthesized and their inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) were evaluated. 4-allyl-2-methoxyphenyl-(3,4- dicholorophenyl)carbamate (3f) was found to be the most potent AChE inhibitor with IC50 value of 71.6 µM, and 4- allyl-2-methoxyphenyl(3-methoxyphenyl)carbamate (3a) exhibited the strongest inhibition against BuChE with IC50 value of 0.58 µM. Additionally, structure-activity relationship were also investigated.
___
- O. di Pietro, E. Viayna, E. V. Garcia, M.
Bartolini, R. Ramon, J. J. Jimenez, M. V. Clos,
B. Perez, V. Andrisano, F. J. Luque, R. Lavilla,
and D. M. Torrero, “1,2,3,4-
Tetrahydrobenzo[h][1,6]naphthyridines as a new
family of potent peripheral-to-midgorge-site
inhibitors of acetylcholinesterase: Synthesis,
pharmacological evaluation and mechanistic
studies,” Eur. J. Med. Chem., vol. 73, pp. 141-
152, Feb. 2014.
- P. M. Ruiz, L. Rubio, E. G. Palomero, I.
Dorronsoro, M. M. Millan, R. Valenzuela, P.
Usan, C. de Austria, M. Bartolini, V. Andrisano,
A. B. Chanal, M. Orozco, F. J. Luque, M.
Medina, and A. Martinez, “Design, synthesis,
and biological evaluation of dual binding site
acetylcholinesterase inhibitors: New diseasemodifying
agents for alzheimer’s disease,” J.
Med. Chem., vol. 48, no. 23, pp. 7223-7233, Oct.
2005.
- M. Ignasik, M. Bajda, N. Guzior, M. Prinz, U.
Holzgrabe, and B. Malawska, “Design, synthesis
and evaluation of novel 2-(aminoalkyl)-
isoindoline-1,3-dione derivatives as dualbinding
site acetylcholinesterase inhibitors,”
Arch. Pharm. Chem. Life Sci., vol. 345, no. 7,
pp.509-516, Mar. 2012.
- F. C. Meng, F. Mao, W. J. Shan, F. Qin, L.
Huang, and X. S. Li, “Design, synthesis, and
evaluation of indanone derivatives as
acetylcholinesterase inhibitors and metalchelating
agents,” Bioorg. Med. Chem. Lett., vol.
22, no. 13, pp. 4462–4466, Jul. 2012.
- S. S. Xie, X. B. Wang, J. Y. Li, L. Yang, and L.
Y. Kong, “Design, synthesis and evaluation of
novel tacrineecoumarin hybrids as
multifunctional cholinesterase inhibitors against
Alzheimer’s disease,” Eur. J. Med. Chem., vol.
64, pp. 540-553, Jun. 2013.
- M. Shidore, J. Machhi, K. Shingala, P.
Murumkar, M. K. Sharma, N. Agrawal, A.
Tripathi, Z. Parikh, P. Pillai, and M. R. Yadav,
“Benzylpiperidine-linked diarylthiazoles as
potential anti-alzheimer’s agents: Synthesis and
biological evaluation,” J. Med. Chem., vol. 59,
no. 12, pp. 5823–5846, Jun. 2016.
- Q. Yu, H. W. Holloway, T. Utsuki, A. Brossi,
and N. H. Greig, “Synthesis of novel phenserinebased-selective
inhibitors of
butyrylcholinesterase for alzheimer’s disease,” J. Med. Chem., vol. 42, no. 10, pp. 1855-1861, May
1999.
- Z. P. Wu, X. W. Wu, T. Shen, Y. P. Li, X. Cheng,
L. Q. Gu, Z. S. Huang, and L. K. An, “Synthesis
and acetylcholinesterase and
butyrylcholinesterase inhibitory activities of 7-
alkoxyl substituted indolizinoquinoline-5,12-
dione derivatives,” Arch. Pharm. Chem. Life
Sci., vol. 345, no. 3, pp. 175–184, Oct. 2012.
- N. Chitranshi, S. Gupta, P. K. Tripathi, and P. K.
Seth, “New molecular scaffolds for the design of
Alzheimer’s acetylcholinesterase inhibitors
identified using ligand- and receptor-based
virtual screening,” Med. Chem. Res., vol. 22, no.
5, pp. 2328–2345, May 2013.
- C. Guillou, A. Mary, D. Z. Renko, E. Gras, and
C. Thal, “Potent acetylcholinesterase inhibitors:
design, synthesis and structure-activity
relationships of alkylene linked bisgalanthamine
and galanthamine-galanthaminium
salts,” Bioorg. Med. Chem. Lett., vol. 10, no. 7,
pp. 637-639, Apr. 2000.
- H. Göçer, A. Akincioğlu, S. Göksu, İ. Gülçin,
and C. T. Supuran, “Carbonic anhydrase and
acetylcholinesterase inhibitory effects of
carbamates and sulfamoylcarbamates,” J.
Enzyme Inhib. Med. Chem., vol. 30, no. 2, pp.
316-320, 2015.
- M. Pohanka, “Acetylcholinesterase inhibitors: a
patent review (2008-present),” Expert Opin.
Ther. Pat., vol. 22, no. 8, pp. 871-886, Jul. 2012.
- M. L. Bolognesi, M. Bartolini, A. Cavalli, V.
Andrisano, M. Rosini, A. Minarini, and C.
Melchiorre, “Design, synthesis, and biological
evaluation of conformationally restricted
rivastigmine analogues,” J. Med. Chem., vol. 47,
no. 24, pp. 5945-5952, Oct. 2004.
- S. Darvesh, K. V. Darvesh, R. S. McDonald, D.
Mataija, R. Walsh, S. Mothana, O. Lockridge,
and E. Martin, “Carbamates with differential
mechanism of inhibition toward
acetylcholinesterase and butyrylcholinesterase,”
J. Med. Chem., vol. 51, no. 14, pp. 4200–4212,
Jun. 2008.
- J. C. Verheijen, K. A. Wiig, S. Du, S. L. Connors,
A. N. Martin, J. P. Ferreira, V. I. Slepnev, and U.
Kochendörfer, “Novel carbamate cholinesterase
inhibitors that release biologically active amines
following enzyme inhibition,” Bioorg. Med.
Chem. Lett., vol. 19, no. 12, pp. 3243–3246, Jun.
2009.
- M. J. Balunas, and A. D. Kinghorn, “Drug
discovery from medicinal plants,” Life Sci., vol.
78, no. 5, pp. 431–441, Dec. 2005.
- M. Jukic, O. Politeo, M. Maksimovic, M. Milos,
and M. Milos, “In vitro acetylcholinesterase
inhibitory properties of thymol, carvacrol and
their derivatives thymoquinone and
thymohydroquinone,” Phytother. Res., vol. 21,
no. 3, pp. 259–261, Mar. 2007.
- J. Mastelic, I. Jerkovic, I. Blazevic, M. P. Blazi,
S. Borovic, I. I. Bace, V. Smrecki, N. Zarkovic,
K. B. Kostic, D. V. Topic, and N. Muller,
“Comparative study on the antioxidant and
biological activities of carvacrol, thymol, and
eugenol derivatives,” J. Agric. Food Chem., vol.
56, no. 11, pp. 3989-3996, May 2008.
- H. Sadeghian, S. M. Seyedi, M. R. Saberi, Z.
Arghiani, and M. Riazi, “Design and synthesis of
eugenol derivatives, as potent 15-lipoxygenase
inhibitors,” Bioorg. Med. Chem., vol. 16, no. 2,
pp. 890-901, Jan. 2008.
- J. D. Barbosa, V. B. Silva, P. B. Alves, G.
Gumina, R. L. Santos, D. P. Sousa, and S. C.
Cavalcanti, “Structure–activity relationships of
eugenol derivatives against Aedes aegypti
(Diptera: Culicidae) larvae,” Pest Manag. Sci.,
vol. 68, no. 11, pp. 1478-1483, Jun. 2012.
- N. Chaibakhsh, M. Basri, S. H. M. Anuar, M. B.
A. Rahman, and M. Rezayee, “Optimization of
enzymatic synthesis of eugenol ester using
statistical approaches,” Biocatal. Agric.
Biotechnol., vol. 1, no. 3, pp. 226-231, Jul. 2012.
- G. D. Yadav, and A. R. Yadav, “Insight into
esterification of eugenol to eugenol benzoate
using a solid super acidic modified zirconia
catalyst UDCaT-5,” Chem. Eng. J., vol. 192, pp.
146-155, Jun. 2012.
- S. Dohi, M. Terasaki, and M. Makino,
“Acetylcholinesterase inhibitory activity and
chemical composition of commercial essential
oils,” J. Agric. Food Chem., vol. 57, no. 10, pp.
4313-4318, Apr. 2009.
- I. Orhan, M. Kartal, Y. Kan, and B. Şener,
“Activity of essential oils and individual
components against acetyl- and
butyrylcholinesterase,” Z. Naturforsch. C, vol.
63, no. 7-8, pp. 547-553, Aug. 2008.
- G. L. Ellman, K. D. Courtney, V. Andres, and R.
M. Featherstone, “A new and rapid colorimetric
determination of acetylcholinesterase activity,”
Biochem. Pharmacol., vol. 7, no. 2, pp. 88–95,
Jul. 1961.